These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5339995)

  • 21. Reserpine added to neuroleptic-tricyclic in refractory schizophrenics.
    Bacher N; Lewis H
    J Clin Psychiatry; 1981 Aug; 42(8):326. PubMed ID: 7019202
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological studies on 5-(3-(4-piperidino-4-carbamoyl-piperidino)-propyl)-10,11-dihydro-5(H)-dibenz-(b,f)-azepine (carpipramine) dihydrochloride, a new psychotropic agent.
    Nakanishi M; Tsumagari T; Okada T; Kasé Y
    Arzneimittelforschung; 1968 Nov; 18(11):1435-41. PubMed ID: 5755909
    [No Abstract]   [Full Text] [Related]  

  • 23. The blockade of the pressor response to tyramine by amphetamine in the reserpine-treated dog.
    Eble JN; Rudzik AD
    J Pharmacol Exp Ther; 1966 Jul; 153(1):62-9. PubMed ID: 5921358
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of phenelzine and imipramine in depressed inpatients.
    Davidson JR; McLeod MN; Turnbull CD; Miller RD
    J Clin Psychiatry; 1981 Oct; 42(10):395-7. PubMed ID: 7026542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive effects of metoprolol and reserpine-hydrochlorothiazide.
    Lochaya S; Jansiriskul V; Srivorpongpan R; Jiamsucson K; Suvachittanont O
    J Med Assoc Thai; 1982 Apr; 65(4):203-12. PubMed ID: 7050277
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: p-Chlorophenylalanine in schizophrenia.
    Casacchia M; Casati C; Fazio C
    Biol Psychiatry; 1975 Feb; 10(1):109-10. PubMed ID: 123471
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of chronic schizophrenics using high doses of reserpine].
    Rodríguez Suárez FJ; Concepción Pérez A
    Actas Luso Esp Neurol Psiquiatr; 1968 Nov; 27(4):556-92. PubMed ID: 5743478
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical experiences with the antihypertensive agent Darebon].
    Iser H; Marburger P
    Med Welt; 1969 Jun; 26():1493-7. PubMed ID: 5801901
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparison of pharmacological activity and toxicity of the antidepressants nialamide, phenelzine and iproniazide].
    Lapin IP; Samsonova ML
    Farmakol Toksikol; 1969; 32(5):526-30. PubMed ID: 5364661
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacological properties of 2,3,3a,4,5,6-hexahydro-8-methyl-1H-pyrazino [3,2,1-j,k]carbazol hydrochloride (pirlindole), a new antidepressant.
    Mashkovsky MD; Andrejeva NI
    Arzneimittelforschung; 1981; 31(1):75-9. PubMed ID: 7194096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Very high reserpine dosage in the treatment of chronic schizophrenia].
    Häfner H; Schliack E; Zenz H
    Ger Med Mon; 1967 Dec; 12(12):601-2. PubMed ID: 5584830
    [No Abstract]   [Full Text] [Related]  

  • 32. Behavior "recovery" during chronic reserpine treatment: effect of dose of reserpine.
    Pirch JH
    Psychopharmacologia; 1969; 16(3):253-60. PubMed ID: 5364173
    [No Abstract]   [Full Text] [Related]  

  • 33. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.
    Wooters TE; Bardo MT
    Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind trial of reserpine in small doses as an adjunct in the treatment of hyperthyroidism.
    Cheah JS
    Med J Aust; 1972 Feb; 1(7):322-4. PubMed ID: 4554305
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the question of differences between therapeutic responses after particular neuroleptics in comparison to perphenazine in schizophrenics (author's transl)].
    Náhunek K; Svestka J; Cesková E
    Cesk Psychiatr; 1981 Feb; 77(1):25-30. PubMed ID: 6113897
    [No Abstract]   [Full Text] [Related]  

  • 36. [Buronil (FG 5111)--a new butyrophenone derivative. A controlled clinical study on senile dementia and confusion].
    Simmelsgaard H; Mellergaard M; Vangtorp A
    Nord Med; 1967 Feb; 77(7):210-3. PubMed ID: 5336427
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of hypertension with a new kind of drug combination].
    Emich R; Roiko G
    Wien Med Wochenschr; 1968 Oct; 118(40):822-5. PubMed ID: 5710853
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of hypertensive patients with adelphan-esidrex].
    Shvedenko LA; Parashchak AP; Ryzhova VL
    Klin Med (Mosk); 1983 Aug; 61(8):24-8. PubMed ID: 6358666
    [No Abstract]   [Full Text] [Related]  

  • 40. Centrally mediated peripheral hypotensive effects of reserpine and hydralazine when perfused through the isolated in situ cat brain.
    Ingenito AJ; Barrett JP; Procita L
    J Pharmacol Exp Ther; 1969 Dec; 170(2):210-20. PubMed ID: 5355977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.